Skip to main content
. 2020 Sep 14;11(11):3155–3167. doi: 10.1111/1759-7714.13634

Table 1.

The P‐value of each group in LUAD samples in Fig 1

Patients’ smoking habit Cancer stages
Comparison P‐value Comparison P‐value
Normal vs. non‐smoker <0.05 Normal vs. stage 1 <0.05
Normal vs. smoker <0.05 Normal vs. stage 2 <0.05
Normal vs. reformed smoker 1 <0.05 Normal vs. stage 3 <0.05
Normal vs. reformed smoker 2 <0.05 Normal vs. stage 4 <0.05
Non‐smoker vs. smoker >0.05 Stage 1 vs. stage 2 >0.05
Non‐smoker vs. reformed smoker 1 >0.05 Stage 1‐ vs. stage 3 >0.05
Non‐smoker vs. reformed smoker 2 >0.05 Stage 1 vs. stage 4 >0.05
Smoker vs. reformed smoker 1 >0.05 Stage 2 vs. stage 3 >0.05
Smoker vs. reformed smoker 2 >0.05 Stage 2 vs. stage 4 >0.05
Reformed smoker 1 vs. reformed smoker 2 >0.05 Stage 3 vs. stage 4 >0.05
Patients’ gender
Comparison P‐value Comparison P‐value
Normal vs. male <0.05
Normal vs. female <0.05
Male vs. female >0.05
Patients’ age Nodal metastasis status
Comparison P‐value Comparison P‐value
Normal vs. age (21–40 years) >0.05 Normal vs. N0 <0.05
Normal vs. age (41–60 years) <0.05 Normal vs. N1 <0.05
Normal vs. age (61–80 years) <0.05 Normal vs. N2 <0.05
Normal vs. age (81–100 years) <0.05 Normal vs. N3 >0.05
Age (21–40 years) vs. age (41–60 years) >0.05 N0 vs. N1 >0.05
Age (21–40 years) vs. age (61–80 years) >0.05 N0 vs. N2 >0.05
Age (21–40 years) vs. age (81–100 years) >0.05 N0 vs. N3 >0.05
Age (41–60 years) vs. age (61–80 years) >0.05 N1 vs. N2 <0.05
Age (41–60 years) vs. age (81–100 years) >0.05 N1 vs. N3 >0.05
Age (61–80 years) vs. age (81–100 years) >0.05 N2 vs. N3 >0.05

N0, no regional lymph node metastasis; N1, metastases in 1 to 3 axillary lymph nodes; N2, metastases in 4 to 9 axillary lymph nodes; N3, metastases in 10 or more axillary lymph nodes.